Outsourced Pharma Capacity Update (April 2025): Large Molecule

Join Rasmus Pedersen, Associate Director for kojoX and Technology Development, at the Large Molecule Capacity Update on April 22. Hear how FUJIFILM Diosynth Biotechnologies is addressing surging market demands for mammalian cell culture therapies through:

– Major investments into expanding our 5-20K L fed batch and continuous global manufacturing facilities, with a new 20K L site coming on-line in Summer 2025 to support large scale commercial manufacturing

– Creating an integrated and harmonized kojoX network that accelerates technology transfers and enhances supply chain agility and resilience.

Join us to learn how our kojoX global network, built for speed, scalability, supply chain agility and resilience, is helping our partners bring life changing therapies to the market more reliably and faster than ever.